Records 1 - 3
| A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
Oncogene 2015 Jan .
Wang N, Ding H, Liu C, Li X, Wei L, Yu J, Liu M, Ying M, Gao W, Jiang H, Wang
| CDC 25A gene 263C/T, -350C/T, and -51C/G polymorphisms in breast carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010 Dec 31 (6): 597-604.
Karagoz Isik Didem, Ozaslan Mehmet, Cengiz Beyhan, Kalender Mehmet Emin, Kilic Ibrahim Halil, Oztuzcu Serdar, Gogebakan Bulent, Demiryurek Abdullah Tunc
| The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
British journal of cancer 2004 Feb 90 (4): 888-91.
Koppert L B, Schutte M, Abbou M, Tilanus H W, Dinjens W N